Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.74 EUR | +1.82% | +0.08% | -30.41% |
31/05 | Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment | MT |
31/05 | Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.41% | 1.81B | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- GLPG Stock
- News Galapagos NV
- Galapagos Partners with Blood Centers of America to Decentralize CAR-T Cell Therapy Manufacture